MedPath

Application to Improve Patient Engagement and Decrease Postoperative Opioid Consumption in Patients for Colorectal Surgery

Completed
Conditions
Colorectal Surgery
Interventions
Behavioral: SeamlessMD® Mobile Application
Registration Number
NCT06350916
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The purpose of this study is to evaluate whether patient-centered educational material delivered before and immediately after surgery can help improve outcomes for patients undergoing colorectal surgery.

Detailed Description

To analyze the impact of implementation of patient-centered educational material delivered the SeamlessMD® mobile application on perioperative Enhanced Recovery After Surgery (ERAS) metric completion rates among patients undergoing elective colorectal surgery. This is a non-interventional, prospective feasibility study. The planned study period will encompass adult patients (\>18 years) scheduled to undergo an elective colorectal surgery procedure at CMC-Main during the six-month period of December 2020 to May 2021. Patients enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation, five days prior to surgery, three days postoperatively, and 30 days postoperatively.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Adult patients (>18 years old)
  • Scheduled to undergo an elective colorectal surgery procedure (for benign or malignant colon or rectal pathology) at CMC-Main by one of the 5 participating colorectal surgeons (Davis, Hill, Kasten, Salo, Squires)
  • Ability to provide informed consent
Read More
Exclusion Criteria
  • Emergent, non-elective colorectal procedures
  • Non-English speaking
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SeamlessMD Mobile ApplicationSeamlessMD® Mobile ApplicationParticipants enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation over 30 days. Participants will also be prompted by the app to record their daily narcotic consumption via an "Opioid Tracker" page that requests participants enter the number of doses taken for each narcotic medication in the last 24 hours.
Primary Outcome Measures
NameTimeMethod
30-day readmission30 Days Following Hospital Discharge

Readmission to any hospital facility as inpatient within 30 days of surgery

Perioperative ERAS metric completion rate30 Days Following Hospital Discharge

Completion rate for perioperative ERAS metrics

Postoperative hospital length of stay30 Days Following Hospital Discharge

Postoperative hospital length of stay

Postoperative complications30 Days Following Hospital Discharge

Occurrence of postoperative complications within 30 days, classified as Clavien-Dindo Grade I-V

Secondary Outcome Measures
NameTimeMethod
Postoperative Opioid Consumption30 Days Following Hospital Discharge

Postoperative opioid consumption in morphine equivalent daily doses (MEDDs) as extracted from the medical administration record (MAR) for the inpatient hospitalization period

Trial Locations

Locations (1)

Levine Cancer Institute

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath